VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
SABSSAB Biotherapeutics, Inc.
$4.00$214M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSABSPrice History

SABS logoSAB Biotherapeutics, Inc. (SABS) Stock Price History

Historical prices from 2021 to 2026

$4.00+0.14  (+3.63%)close Jun 18
Returns
1M
+12.4%
3M
+8.1%
YTD
+6.1%
1Y
+124.7%
3Y
-23.1%
5Y
-47.4%
ATH$129.00Oct 2021-96.9%
ATL$1.00Apr 2025pre-split
Avg Vol (50D)845K/ day
52-Week Range$1.67 — $6.60
LowCurrent: $4.00High

Loading 10-year price history...

SABS Historical Performance

1 YearTotal Return
+124.7%
Price: +124.7%
3 YearsTotal Return
-54.5%
CAGR: -23.1%
Price: -54.5%
5 YearsTotal Return
-96.0%
CAGR: -47.4%
Price: -96.0%
YTD
+6.1%

SABS Annual Returns

Year-by-year price performance · 2021–2026

Best+5.8%2023
Worst-93.1%2022
Up years3/6
2021-23.1%
2022-93.1%
2023+5.8%
2024-45.9%
2025+0.8%
2026+8.8%
2021 annual price return
-23.1%
2022 annual price return
-93.1%
2023 annual price return
+5.8%
2024 annual price return
-45.9%
2025 annual price return
+0.8%
2026 annual price return
+8.8%
LessMore
Alpha vs S&P 500
1Y+99.7%
3Y-43.6%
5Y-60.2%

Price returns only.

Download Historical Data

1,347 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SABS Stock Price Trajectory (2021–2026)

As of June 22, 2026, SAB Biotherapeutics, Inc. (SABS) trades at $4.00, representing a +124.7% return over the past year. The stock has delivered a -96.0% total return over five years (-47.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $129.00 on October 22, 2021. From this peak, SABS has corrected -96.9%, currently trading 14% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+122.8% 1Y), ARGX (+63.2% 1Y), and HALO (+29.0% 1Y), SABS has underperformed the peer group average. Compare SABS vs IMVT →

SABS Historical Price Data · from 2021

Rows 1–50 of 1,347
Date Open High Low Close Volume Change %
2026-06-183.934.103.854.002.36M+3.63%
2026-06-173.723.893.663.86710K+5.46%
2026-06-163.914.003.663.661.91M-6.15%
2026-06-153.523.993.523.905.96M+17.12%
2026-06-123.403.553.333.33347K-1.48%
2026-06-113.343.403.303.38239K+2.11%
2026-06-103.353.453.313.31213K-1.49%
2026-06-093.443.503.353.36361K-1.18%
2026-06-083.403.443.333.40349K+0.59%
2026-06-053.473.473.283.3833K-2.59%
2026-06-043.353.503.323.47304K+3.27%
2026-06-033.473.493.323.36327K-3.45%
2026-06-023.503.543.413.48465K+1.16%
2026-06-013.713.743.413.44503K-4.44%
2026-05-293.563.643.523.60223K+0.84%
2026-05-283.593.653.553.57134K-0.83%
2026-05-273.783.843.593.60280K-5.51%
2026-05-263.893.923.733.81444K-2.31%
2026-05-223.853.973.853.90318K+2.36%
2026-05-213.653.823.593.81368K+3.53%
2026-05-203.703.853.673.68564K+3.66%
2026-05-193.543.603.403.55482K-0.28%
2026-05-183.683.743.443.56770K-3.78%
2026-05-153.843.883.593.70939K-4.88%
2026-05-144.034.123.793.89707K-1.77%
2026-05-133.624.043.573.96753K+9.39%
2026-05-123.803.813.553.62825K-2.69%
2026-05-114.214.273.673.722.62M-9.49%
2026-05-084.164.593.794.115.27M+0.49%
2026-05-074.384.453.774.093.27M+7.63%
2026-05-063.733.983.633.80709K+3.26%
2026-05-053.663.703.553.68361K-0.27%
2026-05-043.453.793.453.69667K+6.34%
2026-05-013.723.823.463.47626K-7.22%
2026-04-303.493.843.493.74644K+7.47%
2026-04-293.513.583.413.48322K-1.42%
2026-04-283.473.553.433.53233K+1.73%
2026-04-273.523.653.443.47424K-1.42%
2026-04-243.713.753.513.52555K-7.37%
2026-04-233.994.073.793.80465K-4.76%
2026-04-223.854.013.803.99442K+4.72%
2026-04-213.873.873.683.81413K-1.30%
2026-04-203.853.923.753.86256K+0.26%
2026-04-173.974.033.833.85344K-1.79%
2026-04-164.024.053.873.92308K-3.21%
2026-04-153.864.083.804.05879K+4.92%
2026-04-143.953.983.833.86618K-1.03%
2026-04-133.813.943.733.90265K+4.00%
2026-04-103.833.843.733.75194K-2.09%
2026-04-093.713.863.653.83232K+2.68%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SABS — Frequently Asked Questions

Quick answers to the most common questions about buying SABS stock.

How has SABS stock performed recently?

SABS returned +124.7% over the past year, beating its 5-year annualized CAGR of -47.4%. The stock trades above its 200-day moving average, confirming the uptrend.

What is SABS's all-time high price?

SAB Biotherapeutics, Inc. reached $129.00 on 2021-10-22. The 52-week high is $6.60. Current 1-year return of +124.7% places the stock closer to historical peaks.

Where can I download SABS historical price data?

This page provides SABS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

450 data points · sampled from 1,347